Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by PoorOpinionon Mar 18, 2018 11:38am
93 Views
Post# 27735629

RE:RE:RE:RE:RE:RE:RE:RE:RE:Why TH needs to trade in the US

RE:RE:RE:RE:RE:RE:RE:RE:RE:Why TH needs to trade in the USIt's maybe only realistic that TH  will get taken serious for a NASDAQ listing once we get to see some actual Trogarzo sales in which case SPCEO gets what he wants, a little wait though, and JFM gets some of his higher valuation if those sales are good.

Maybe the huge relief/release from the approval finally happening has caused a loss of patience.

Question. Would a new listing on NASDAQ be a opportunity for large shareholders/insiders to unload some shares? As well as new PP shares, institutions coming in to the stock can also get big blocks of shares from pre-existing large shareholders. SPCEO you looking for an exit for some of your holding? You're annual report had a big emphasis on a market correction. You looking to reduce your general exposure? Do I think you have ulterior motives? Yes. Do I think everybody has ulterior motives? Yes. Clearly you dont have to answer this, the working of your business are your own affair.
Bullboard Posts